BRPI0912478A2 - sal de r-(+)-lansoprazol alquilamina, processo para preparar um sal de r-(+)-lansoprazol alquilamina estável e forma de dosagem farmacêutica - Google Patents

sal de r-(+)-lansoprazol alquilamina, processo para preparar um sal de r-(+)-lansoprazol alquilamina estável e forma de dosagem farmacêutica

Info

Publication number
BRPI0912478A2
BRPI0912478A2 BRPI0912478A BRPI0912478A BRPI0912478A2 BR PI0912478 A2 BRPI0912478 A2 BR PI0912478A2 BR PI0912478 A BRPI0912478 A BR PI0912478A BR PI0912478 A BRPI0912478 A BR PI0912478A BR PI0912478 A2 BRPI0912478 A2 BR PI0912478A2
Authority
BR
Brazil
Prior art keywords
lansoprazole
alkylamine salt
preparing
stable
dosage form
Prior art date
Application number
BRPI0912478A
Other languages
English (en)
Inventor
Arjun Bodkhe
Manjunath Narayan Bhanu
Samir Naik
Original Assignee
Watson Pharma Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Pharma Private Ltd filed Critical Watson Pharma Private Ltd
Publication of BRPI0912478A2 publication Critical patent/BRPI0912478A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0912478A 2008-05-14 2009-05-12 sal de r-(+)-lansoprazol alquilamina, processo para preparar um sal de r-(+)-lansoprazol alquilamina estável e forma de dosagem farmacêutica BRPI0912478A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1036MU2008 2008-05-14
PCT/IN2009/000279 WO2010079504A2 (en) 2008-05-14 2009-05-12 Stable r(+)-lansoprazole amine salt and a process for preparing the same

Publications (1)

Publication Number Publication Date
BRPI0912478A2 true BRPI0912478A2 (pt) 2016-02-10

Family

ID=42237245

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912478A BRPI0912478A2 (pt) 2008-05-14 2009-05-12 sal de r-(+)-lansoprazol alquilamina, processo para preparar um sal de r-(+)-lansoprazol alquilamina estável e forma de dosagem farmacêutica

Country Status (7)

Country Link
US (1) US8362042B2 (pt)
EP (1) EP2303868A2 (pt)
AU (1) AU2009336561A1 (pt)
BR (1) BRPI0912478A2 (pt)
NZ (1) NZ589150A (pt)
WO (1) WO2010079504A2 (pt)
ZA (1) ZA201008188B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100280077A1 (en) * 2007-12-18 2010-11-04 Watson Pharma Private Limited Process for Preparation of Stable Amorphous R-Lansoprazole
EP2303868A2 (en) 2008-05-14 2011-04-06 Watson Pharma Private Limited Stable r(+)-lansoprazole amine salt and a process for preparing the same
CN102875530A (zh) * 2011-07-15 2013-01-16 上海睿智化学研究有限公司 一种(r)-兰索拉唑叔丁胺盐及其晶型和制备方法
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
CN104130244B (zh) * 2014-07-29 2017-09-26 上海右手医药科技开发有限公司 右兰索拉唑甲胺盐化合物及其制备方法和药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CN1117747C (zh) 2000-06-19 2003-08-13 中国科学院成都有机化学研究所 光学纯兰索拉唑的制备方法
JP5412023B2 (ja) * 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
KR20100002278A (ko) * 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
WO2004035052A1 (ja) 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
MX2008016196A (es) * 2006-07-05 2009-01-20 Lupin Ltd Proceso para la preparacion de enantiomeros opticamente puros u opticamente enriquecidos de compuestos de sulfoxido.
US20100280077A1 (en) * 2007-12-18 2010-11-04 Watson Pharma Private Limited Process for Preparation of Stable Amorphous R-Lansoprazole
EP2303868A2 (en) 2008-05-14 2011-04-06 Watson Pharma Private Limited Stable r(+)-lansoprazole amine salt and a process for preparing the same

Also Published As

Publication number Publication date
ZA201008188B (en) 2012-03-28
WO2010079504A2 (en) 2010-07-15
US8362042B2 (en) 2013-01-29
EP2303868A2 (en) 2011-04-06
NZ589150A (en) 2012-03-30
US20110065755A1 (en) 2011-03-17
AU2009336561A1 (en) 2010-07-15
WO2010079504A3 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
BRPI0910734A2 (pt) composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0918038A2 (pt) Processos para preparar um composto e um sal, e, composto
BR112013009486A2 (pt) processo para preparação de formas de dosagem gastrirretentivas multiparticuladas
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
SMT201500209B (it) Forme di dosaggio farmaceutiche a rilascio controllato
BRPI0919018A2 (pt) sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal
BRPI1006534A2 (pt) sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1
PL2257305T3 (pl) Nowy farmaceutyczny preparat do leczenia stanu przedrzucawkowego
BR112014007645A2 (pt) composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica
HUE046557T2 (hu) Tapentadolt tartalmazó vizes gyógyszerészeti készítmény szájon át alkalmazásra
BRPI0923007A2 (pt) Sal de piperazina e um processo para preparação do mesmo
BRPI0913873A2 (pt) recipiente para dose única
IL258357A (en) A semi-solid aqueous pharmaceutical preparation containing tapentadol
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0814821A2 (pt) Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI0922836A2 (pt) processo para a preparação de um sal de succinato monovalente
BRPI0910785A2 (pt) sal de eritromicina hidratado, composição farmacêutica, processo para preparar um sal de eritromicina hidratado e uso de sal de eritromicina hidratado
BR112013007040A2 (pt) "método para preparar um composto e composto"
BRPI0922714A2 (pt) composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica
BR112014007568A2 (pt) composição farmacêutica, uso e processo para preparar a mesma
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BRPI0815975A2 (pt) Preparação aquosa, recipiente farmacêutico, processo para preparar uma preparação aquosa, e, uso de uma preparação aquosa

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]